Biogen (BIIB) PT Lowered to $382 at SVB Leerink
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $209.83 --0%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
SVB Leerink analyst Marc H. Goodman lowered the price target on Biogen (NASDAQ: BIIB) to $382.00 (from $402.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
- Johnson Rice Upgrades Magnolia Oil & Gas Corp. (MGY) to Accumulate
- Johnson Rice Downgrades Expand Energy (EXE) to Accumulate
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
